Goldman Sachs’s ProShares Ultra CRCL CRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$768K Buy
+44,126
New +$774K ﹤0.01% 5438

Other funds holding CRCA

Goldman Sachs's CRCA Position: Q3 2026 in Review

Goldman Sachs opened a new position in ProShares Ultra CRCL (CRCA) in Q3 2026: 44,126 shares worth $768K. The stake represents ﹤0.01% of the portfolio and ranks #5438 among its holdings.

8 funds tracked by Wall St. Rank hold CRCA as of Q3 2026.

  • Goldman Sachs held 44,126 shares of ProShares Ultra CRCL worth $768K as of Q3 2026.
  • ProShares Ultra CRCL was a new Goldman Sachs position in Q3 2026.
  • ProShares Ultra CRCL made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #5438 holding.
  • 8 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.